Tumor-derived factors, such as pro-inflammatory cytokines IL-6 and IL-1β, promote the formation of MDSCs resulting in their accumulation in the blood, lymphoid organs and tumor [18,19]. The gene discussed is IL6; the disease is neoplasm.